Tushar Pandey: Hounoured to Be Part of Hematocon 2025
Tushar Pandey, Editorial Board Member at Journal of Cancer Chemotherapy, shared on LinkedIn:
”HONOURED TO BE PART OF HEMATOCON 2025
Grateful for the opportunity to represent HALDWANI, UTTARAKHAND and the RAGHAV INSTITUTE OF HEMATOLOGY, HEMATO-ONCOLOGY and BONE MARROW TRANSPLANT (RIHOB) as FACULTY at the National Hematology Conference — Hematocon 2025.
Participated in a deeply insightful session on “INFECTIONS IN BONE MARROW TRANSPLANT AND NEUTROPENIC SETTINGS AND THEIR MANAGEMENT,” an area that remains vital to improving outcomes and safety in hematology and transplant care.
It was a privilege to share thoughts and exchange ideas with distinguished HEMATOLOGISTS — DR. Faheema Hasan , DR. ADITYA JANDIAL, DR. POORVI KAPOOR, AND DR. SAYAN ROY.
The discussion brought forward valuable perspectives on managing complex infections in immunocompromised patients.
Looking forward to continuing our collective efforts to strengthen hematology and transplant services across UTTARAKHAND AND NORTH INDIA.
Committed to advancing excellence in Hematology, Oncology and BMT care.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
-
May 24, 2026, 05:48Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management